Wolverine Trading’s Forte Biosciences FBRX Stock Holding History

Wolverine Trading’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,241	Closed	-$83.5K	–	6167
2021 Q3	$95K	Buy	+1,241	New	+$688K	﹤0.01%	5797

Other funds holding FBRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wolverine Trading's FBRX Position: Q4 2021 in Review

Wolverine Trading sold out of Forte Biosciences (FBRX) in Q4 2021, closing a stake of 1,241 shares — an estimated $83.5K sold.

Wolverine Trading first reported a position in FBRX in Q3 2021 and held it in 1 quarter. The position peaked at $95K in Q3 2021. 52 funds tracked by Wall St. Rank hold FBRX as of Q4 2021.

Wolverine Trading reported no remaining Forte Biosciences position as of Q4 2021 after selling out during the quarter.
Wolverine Trading sold 1,241 Forte Biosciences shares in Q4 2021, an estimated $83.5K.
Wolverine Trading first reported a position in Forte Biosciences in Q3 2021 and held it in 1 quarter.
Wolverine Trading's Forte Biosciences position peaked at $95K in Q3 2021.
52 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.